To discuss the Concordat, we are organizing a panel at the Canadian Science Policy Conference 2020. CPSC seeks to connect, convene, develop capacity building, and catalyze research to support effective science policy community and engagement.
We are very excited to have the opportunity to exchange views on COMPEER with executives from research organizations in Canada, the United States and the UK as well as leading experts in the field.
Join us for the Session: “102: Supporting the Research Ecosystem in Times of Crisis: Good Practices for a More Resilient Research “ on Monday, November 16, 2020, from 2:30-4:00 p.m.
Here is the panel’s summary:
The COVID-19 has caused major disruptions and presents great challenges to the research ecosystem. This interactive panel aims to examine COVID-19’s negative impacts and engage the audience in finding effective practices to tackle the effects of the pandemic. The panel will also discuss the implementation of the Concordat on Mitigating COVID-19 Pandemic Effects on Research (“COMPEER”, www.SignCOMPEER.org) which aims to mobilize the efforts of the global research community. Such engagement is necessary to collectively plan for a “new normal”, ensure that everyone participates in enhancing the academic experience, and conduct research in a more sustainable, responsible, and impactful way.
See the full Conference Program: https://sciencepolicyconference.ca/program-2020/
See the full line-up of panelists:
Jean-Christophe Bélisle-Pipon Visiting Researcher, Past President, Harvard University
Dr. Bélisle-Pipon is a Visiting Researcher at the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School. He is an expert in bioethics whose research lies at the interface of health policies, citizen and patient engagement in research and health governance, as well as business practices. His professional experience, working in both the pharmaceutical industry and the government, provided him with an insider’s understanding of the ethical, policy and social dimensions of health technology development and assessment. Dr. Bélisle-Pipon seeks to examine the most pressing ethical issues of our time (e.g., artificial intelligence, health technology assessment, conflicts of interest, science advising to government) and to accompany academics and policy-makers in better engaging the general public in thinking and contributing to solve these issues. As part of his research, he makes recommendations on the appropriate management and resolution of ethical issues for health regulators and industry decision-makers.
His scientific articles have been published in journals such as Bioethics, Ethics, Medicine and Public Health, Healthcare Policy, American Journal of Bioethics, Canadian Medical Association Journal, Journal of Bioethical Inquiry, and Nature Medicine. His research is funded by the Canadian Institutes of Health Research, the Social Sciences and Humanities Research Council of Canada, the Fonds de recherche du Québec–Santé, and the Québec SPOR SUPPORT Unit.
Dr. Bélisle-Pipon is heavily engaged in research governance. Since 2014, he is acting as a trainee adviser to the Québec Chief Scientist, Rémi Quirion, and he has been nominated on the Board of Directors of the Québec Health Research Fund. Last year, he was elected on the Board of Directors of the International Association of Bioethics, and most recently, he has been appointed on the International Advisory Board of Canada’s SPOR Evidence Alliance. Starting January 2021, he will be Assistant Professor in Health Ethics at the Faculty of Health Sciences of Simon Fraser University.
Meaghan Jones Assistant Professor, Dept. of Biochemistry and Medical Genetics, Rady Faculty of Health Sciences, Manitoba
Dr. Meaghan Jones uses a combination of human population epigenetic data and controlled exposure animal models to ask whether epigenetics might serve as a long-term cellular memory of prenatal and early life environments that goes on to affect lifelong health. In particular she is interested in epigenetic marks induced by inhaled pollutants, including tobacco and cannabis smoke, and how these marks might influence health outcomes including asthma and obesity throughout the lifespan. Dr. Jones also has an interest in aging and the phenomenon of epigenetic age. She is an Assistant Professor in the Department of Biochemistry and Medical Genetics in the Rady Faculty of Health Sciences, and a Scientist at the Children’s Hospital Research Institute of Manitoba.
David Sweeney Executive Chair , Research England, UKRI
David Sweeney chairs the Research England Council and provides leadership and oversight of Research England’s strategy and functions. Previously Director of Research and Knowledge Exchange at the Higher Education Funding Council for England (HEFCE), David was appointed as Executive Chair designate of Research England in early 2017, and took a lead role in shaping the new Council and leading the transition of responsibilities from HEFCE into Research England.
Barbara Natalizio Science Program Administrator, Rita Allen Foundation
Dr. Barbara Natalizio supports early-career biomedical researchers through her role as a Science Program Administrator at the Rita Allen Foundation. Dr. Natalizio also serves as the Chair of the Board of Directors of the National Postdoctoral Association, Co-Chair of Cultivating Ensembles in STEM Education and Research, and a Working Group member of Professional Development Hub (pd|hub). Previously, Dr. Natalizio was a Program Officer with the Board on Higher Education and Workforce at the National Academies of Sciences, Engineering, and Medicine and worked in the Division of Graduate Education at the National Science Foundation, as a AAAS Science and Technology Policy Fellow. She earned her bachelor’s degree in biochemistry and history from Montclair State University and her Ph.D. in molecular genetics and microbiology from Duke University.
Rémi Quirion Chief Scientist of Quebec, Government of Quebec
Rémi Quirion is the inaugural Chief Scientist of Quebec and the President of the three Board of Directors of the Fonds de recherche du Québec since July 1st, 2011. A McGill Full Professor, Psychiatry and outgoing Scientific Director at the Douglas Mental Health University Institute. He served as Vice-Dean, Faculty of Medicine at McGill University, as well as Senior University Advisor (Health Sciences Research) in addition to being the CIHR Executive Director, for Alzheimer’s Diseases, from 2009 to 2011. Prof. Quirion was the inaugural Scientific Director of the Institute of Neurosciences, Mental Health and Addiction (INMHA) until March 2009. In addition to being on the Advisory Board of over 15 journals in Psychiatry, Pharmacology, and Neurosciences, he has published 5 books, more than 650 scientific papers and articles. He received many awards and recognitions as: the Médaille de l’Assemblée nationale du Québec; Fellow of the Royal Society of Canada; and was appointed Fellow of the Canadian Academy of Health Sciences. In 2007, Prof. Quirion became a Member of the Order of Canada (O.C.).
Alexandra Cassivi Postdoctoral Researcher, Université Laval
Alexandra Cassivi is a postdoctoral researcher at Université Laval and visiting researcher at the University of Ottawa, working on water accessibility and quality in indigenous and northern communities. She holds a PhD in civil engineering from the University of Victoria, Canada. Her research interests lie in water, sanitation and hygiene (WASH), public health, geography and data science. Alexandra worked as a consultant with the World Bank’s Water Supply and Sanitation (WSS) Global Solution Group and as an intern with the Water, Sanitation and Hygiene unit at the World Health Organization. She is involved in her community through research and teaching, as well as currently engaged as a member of the Comité intersectoriel étudiant (CIÉ) of the Fonds de recherche du Québec (FRQ).